Skip to main content
Top
Published in: Journal of Cancer Education 4/2015

01-12-2015

Public Awareness of Direct-to-Consumer Genetic Tests: Findings from the 2013 U.S. Health Information National Trends Survey

Authors: Tanya Agurs-Collins, Rebecca Ferrer, Allison Ottenbacher, Erika A. Waters, Mary E. O’Connell, Jada G. Hamilton

Published in: Journal of Cancer Education | Issue 4/2015

Login to get access

Abstract

Although the availability of direct-to-consumer (DTC) genetic testing has increased in recent years, the general public’s awareness of this testing is not well understood. This study examined levels of public awareness of DTC genetic testing, sources of information about testing, and psychosocial factors associated with awareness of testing in the USA. Data were obtained from the nationally representative 2013 U.S. Health Information National Trends Survey. Guided by a social-cognitive conceptual framework, univariable and multivariable logistic regressions were conducted to identify factors associated with awareness of DTC genetic tests. Of 3185 participants, 35.6 % were aware of DTC genetic tests, with the majority learning about these tests through radio, television, and the Internet. In the final adjusted model, participants with annual incomes of $99,999 or less had lower odds of being aware of DTC genetic testing (ORs ranging from 0.46–0.61) than did those participants with incomes of $100,000 or more. The odds of awareness of DTC genetic tests were significantly higher for those who actively seek cancer information (OR = 1.91, 95 % CI = 1.36–2.69), use the Internet (OR = 1.81, 95 % CI = 1.05–3.13), and have high numeracy skills (OR = 1.67, 95 % CI = 1.17–2.38). It will be critical for healthcare researchers and practitioners to understand predictors and consequences of the public’s awareness of DTC genetic tests, as well as how such awareness may translate into DTC genetic testing uptake, health behavior change, and ultimately disease prevention.
Literature
3.
go back to reference Lewis NP, Treise D, Hsu SI, Allen WL, Kang H (2011) DTC genetic testing companies fail transparency prescriptions. New Genet Soc 30:291–307CrossRef Lewis NP, Treise D, Hsu SI, Allen WL, Kang H (2011) DTC genetic testing companies fail transparency prescriptions. New Genet Soc 30:291–307CrossRef
6.
go back to reference Langford AT, Resnicow K, Roberts JS, Zikmund-Fisher BJ (2012) Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. J Genet Couns 21:440–447CrossRefPubMed Langford AT, Resnicow K, Roberts JS, Zikmund-Fisher BJ (2012) Racial and ethnic differences in direct-to-consumer genetic tests awareness in HINTS 2007: sociodemographic and numeracy correlates. J Genet Couns 21:440–447CrossRefPubMed
7.
go back to reference Finney Rutten LJ, Gollust SE, Naveed S, Moser RP (2012) Increasing public awareness of direct-to-consumer genetic tests: health care access, internet use, and population density correlates. J Cancer Epidemiol 2012:309109PubMedCentralCrossRefPubMed Finney Rutten LJ, Gollust SE, Naveed S, Moser RP (2012) Increasing public awareness of direct-to-consumer genetic tests: health care access, internet use, and population density correlates. J Cancer Epidemiol 2012:309109PubMedCentralCrossRefPubMed
8.
go back to reference Kolor K, Duquette D, Zlot A et al (2012) Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med 14:860–867CrossRefPubMed Kolor K, Duquette D, Zlot A et al (2012) Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice. Genet Med 14:860–867CrossRefPubMed
9.
go back to reference Foster C, Evans DG, Eeles R et al (2002) Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86:1209–1216PubMedCentralCrossRefPubMed Foster C, Evans DG, Eeles R et al (2002) Predictive testing for BRCA1/2: attributes, risk perception and management in a multi-centre clinical cohort. Br J Cancer 86:1209–1216PubMedCentralCrossRefPubMed
10.
go back to reference Kelly KM, Andrews JE, Case DO, Allard SL, Johnson JD (2007) Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians. J Rural Health 23:166–172CrossRefPubMed Kelly KM, Andrews JE, Case DO, Allard SL, Johnson JD (2007) Information seeking and intentions to have genetic testing for hereditary cancers in rural and Appalachian Kentuckians. J Rural Health 23:166–172CrossRefPubMed
11.
go back to reference Leighton JW, Valverde K, Bernhardt BA (2011) The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics Leighton JW, Valverde K, Bernhardt BA (2011) The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics
12.
go back to reference Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW (2011) Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics 14:279–289PubMedCentralCrossRefPubMed Lea DH, Kaphingst KA, Bowen D, Lipkus I, Hadley DW (2011) Communicating genetic and genomic information: health literacy and numeracy considerations. Public Health Genomics 14:279–289PubMedCentralCrossRefPubMed
13.
go back to reference Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B (2010) Direct-to-consumer genetic testing: good, bad or benign? Clin Genet 77:101–105CrossRefPubMed Caulfield T, Ries NM, Ray PN, Shuman C, Wilson B (2010) Direct-to-consumer genetic testing: good, bad or benign? Clin Genet 77:101–105CrossRefPubMed
14.
go back to reference Cameron LD, Sherman KA, Marteau TM, Brown PM (2009) Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 28:307–316CrossRefPubMed Cameron LD, Sherman KA, Marteau TM, Brown PM (2009) Impact of genetic risk information and type of disease on perceived risk, anticipated affect, and expected consequences of genetic tests. Health Psychol 28:307–316CrossRefPubMed
15.
go back to reference Glanz K, Grove J, Lerman C, Gotay C, Le ML (1999) Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 8:329–336PubMed Glanz K, Grove J, Lerman C, Gotay C, Le ML (1999) Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. Cancer Epidemiol Biomarkers Prev 8:329–336PubMed
16.
go back to reference National Cancer Institute (2014) Health Information National Trends Survey 4 (HINTS 4): Cycle 3 Methodology Report. In Westat (Ed.). Rockville, MD: National Cancer Institute National Cancer Institute (2014) Health Information National Trends Survey 4 (HINTS 4): Cycle 3 Methodology Report. In Westat (Ed.). Rockville, MD: National Cancer Institute
19.
go back to reference Waters EA, Muff J, Hamilton JG (2014) Multifactorial beliefs about the role of genetics and behavior in common health conditions: prevalence and associations with participant characteristics and engagement in health behaviors. Genet Med 16:913–921CrossRefPubMed Waters EA, Muff J, Hamilton JG (2014) Multifactorial beliefs about the role of genetics and behavior in common health conditions: prevalence and associations with participant characteristics and engagement in health behaviors. Genet Med 16:913–921CrossRefPubMed
20.
go back to reference Cline RJ, Haynes KM (2001) Consumer health information seeking on the Internet: the state of the art. Health Educ Res 16:671–692CrossRefPubMed Cline RJ, Haynes KM (2001) Consumer health information seeking on the Internet: the state of the art. Health Educ Res 16:671–692CrossRefPubMed
21.
go back to reference Smerecnik C, Quaak M, van Schayck CP, van Schooten FJ, De Vries H (2011) Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach. Psychol Health 26:1099–1112CrossRefPubMed Smerecnik C, Quaak M, van Schayck CP, van Schooten FJ, De Vries H (2011) Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach. Psychol Health 26:1099–1112CrossRefPubMed
22.
go back to reference Kaphingst KA, Lachance CR, Condit CM (2009) Beliefs about heritability of cancer and health information seeking and preventive behaviors. J Cancer Educ 24:351–356PubMedCentralCrossRefPubMed Kaphingst KA, Lachance CR, Condit CM (2009) Beliefs about heritability of cancer and health information seeking and preventive behaviors. J Cancer Educ 24:351–356PubMedCentralCrossRefPubMed
23.
go back to reference Chen Y, Feeley TH (2014) Numeracy, information seeking, and self-efficacy in managing health: an analysis using the 2007 Health Information National Trends Survey (HINTS). Health Commun 29:843–853CrossRefPubMed Chen Y, Feeley TH (2014) Numeracy, information seeking, and self-efficacy in managing health: an analysis using the 2007 Health Information National Trends Survey (HINTS). Health Commun 29:843–853CrossRefPubMed
24.
go back to reference Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD (2011) Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics 14:178–189PubMedCentralCrossRefPubMed Graves KD, Peshkin BN, Luta G, Tuong W, Schwartz MD (2011) Interest in genetic testing for modest changes in breast cancer risk: implications for SNP testing. Public Health Genomics 14:178–189PubMedCentralCrossRefPubMed
25.
go back to reference Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne E (2014) Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psychooncology Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne E (2014) Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy. Psychooncology
Metadata
Title
Public Awareness of Direct-to-Consumer Genetic Tests: Findings from the 2013 U.S. Health Information National Trends Survey
Authors
Tanya Agurs-Collins
Rebecca Ferrer
Allison Ottenbacher
Erika A. Waters
Mary E. O’Connell
Jada G. Hamilton
Publication date
01-12-2015
Publisher
Springer US
Published in
Journal of Cancer Education / Issue 4/2015
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-014-0784-x

Other articles of this Issue 4/2015

Journal of Cancer Education 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine